Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
Plos One|June 16, 2016
Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieuShiva Mansouri, Grazyna Lietzau, Mathias Lundberg, et al.Diabetes, Obesity & Metabolism|January 5, 2019
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational studyAnna Norhammar, Johan Bodegård, Thomas Nyström, et al.European Journal of Internal Medicine|August 30, 2018
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control studyHenrik Falhammar, Jonatan D Lindh, Jan Calissendorff, et al.Diabetologia|May 19, 2016
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013Anna Norhammar, Johan Bodegård, Thomas Nyström, et al.Diabetes Research and Clinical Practice|January 6, 2017
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemiaThomas Nyström, Johan Bodegard, David Nathanson, et al.Diabetes, Obesity & Metabolism|January 25, 2017
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetesThomas Nyström, Johan Bodegard, David Nathanson, et al.The Journal of Clinical Endocrinology and Metabolism|April 15, 2020
Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population-Based Case-Control StudyHenrik Falhammar, Jakob Skov, Jan Calissendorff, et al.European Journal of Internal Medicine|August 17, 2019
Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control studyHenrik Falhammar, Jan Calissendorff, Jakob Skov, et al.European Journal of Internal Medicine|December 6, 2018
Antipsychotics and severe hyponatremia: A Swedish population-based case-control studyHenrik Falhammar, Jonatan D Lindh, Jan Calissendorff, et al.Diabetes Research and Clinical Practice|June 23, 2016
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortalityJan W Eriksson, Johan Bodegard, David Nathanson, et al.Pageof 12